Laboratory of Experimental Physiology (LeFisio), Department of Physiological Sciences, Biological and Health Sciences Center, Federal University of Maranhão, São Luís, Brazil.
Health Sciences Graduate Program, Biological and Health Sciences Center, Federal University of Maranhão, São Luís, Brazil.
Crit Rev Food Sci Nutr. 2023 Nov;63(33):12285-12293. doi: 10.1080/10408398.2022.2100315. Epub 2022 Jul 14.
The gut microbiota has been extensively investigated during the last decade because of its effects on host neuroendocrine pathways and other processes. The imbalance between beneficial and pathogenic bacteria, known as dysbiosis, may be a determining predisposing factor for many noncommunicable chronic diseases, such as obesity, type 2 diabetes mellitus, metabolic syndrome, and Alzheimer's disease. On the other hand, interventions aiming to reestablish the balance between microbiota components have been suggested as potential preventive therapeutic strategies against these disorders. Among these interventions, dietary supplementation with (poly)phenols has been highlighted due to the modulatory effects exerted by those compounds on the gut microbiota. In addition, (poly)phenol consumption is associated with increased production of short-chain fatty acids (SCFAs), a set of microbial metabolites whose actions are ascribed to improving the abovementioned metabolic disorders. Thus, this review discusses the modulation of the gut microbiota by prebiotic (poly)phenols based on in vivo studies performed with isolated (poly)phenolic compounds, their interaction with the gut microbiota and the production of SCFAs in pursuit of the molecular mechanisms underlying the health effects of (poly)phenols on host metabolism.
在过去的十年中,由于肠道微生物群对宿主神经内分泌途径和其他过程的影响,人们对其进行了广泛的研究。有益细菌和致病细菌之间的失衡,即所谓的生态失调,可能是许多非传染性慢性疾病(如肥胖、2 型糖尿病、代谢综合征和阿尔茨海默病)的决定性诱发因素。另一方面,旨在重新建立微生物群组成之间平衡的干预措施已被提议作为预防这些疾病的潜在治疗策略。在这些干预措施中,由于这些化合物对肠道微生物群的调节作用,(多)酚类的膳食补充剂受到了特别关注。此外,(多)酚类的消耗与短链脂肪酸(SCFA)的产生增加有关,SCFA 是一组微生物代谢物,其作用归因于改善上述代谢紊乱。因此,本综述讨论了基于用分离的(多)酚化合物进行的体内研究,探讨了(多)酚类对肠道微生物群的调节作用,以及(多)酚类与肠道微生物群的相互作用和 SCFA 的产生,以寻求(多)酚类对宿主代谢健康影响的分子机制。